Nicolas Chornet, Senior Vice President of Resilience Operations at Moderna provides insight on how vaccine manufacturers can secure resilience in an environment of rapid technological advancement.
There has been a steady stream of developments in the vaccine manufacturing space throughout 2023. A notable milestone was Moderna’s announcement in April that it had, following finalisation of a ten-year strategic partnership with the UK Government, commenced construction of its mRNA vaccine manufacturing technology centre. Known as MITC, or the Moderna Innovation and Technology Centre, the facility is located in Harwell, Oxfordshire and is expected to become operational in 2025.
To learn more about the current landscape, challenges and most promising solutions for vaccine manufacturing, EPR interviewed Nicolas Chornet, Senior Vice President of Resilience Operations at Moderna.
Technology advancement
Chornet reflected that the pharmaceutical industry has seen changes in the past few years, not only in vaccines manufacturing, but more broadly in the biotech sector, too. Much of this transformation has been the increased speed of development “the speed of arriving [at a] vaccine for the infectious disease and the scale up and… also the manufacturing supply [has accelerated]” he explained.
This report addresses the key factors shaping pharmaceutical formulation, including regulation, QC and analysis.
Access the full report now to discover the techniques, tools and innovations that are transforming pharmaceutical formulation, and learn how to position your organisation for long-term success.
What you’ll discover:
Key trends shaping the pharmaceutical formulation sector
Innovations leading progress in pharmaceutical formulation and how senior professionals can harness their benefits
Considerations and best practices when utilising QbD during formulation of oral solid dosage forms
For new technologies that have emerged in the last five years, “compared to some of the traditional methods, [technologies such as mRNA] are faster, sometimes more accurate also and definitely can be industrialised and manufactured within a shorter period of time. So speed of solution and speed to supply to offer solutions to the public, is much faster,” Chornet explained.
When questioned about which technologies he considered have potential to advance the sector, Chornet emphasised that not only is mRNA as a vaccine technology “a very promising and interesting platform [but that it is] disruptive and a game changer technology for vaccine [manufacturing] and overall biotech.”
there is a big digital revolution coming and biotech and pharmaceutical manufacturing, all the industries, will be impacted positively”
According to Chornet, while it is difficult to foresee the full extent of this transformation, “there is a big digital revolution coming and biotech and pharmaceutical manufacturing, all the industries, will be impacted positively.”
Within pharma, Chornet projected that the technology revolution will impact the industry “end to end… from ordering and controlling raw materials, to the actual manufacturing effort, the operational effort to smart logistics and distribution, and even down to the point of sale.”
Vaccine manufacturing supply chain
Chornet also reflected on the lessons learned from the COVID-19 pandemic and how future supply chain issues could be mitigated. He urged that as an industry “we need to diversify our supply chains. There is a need to have more redundancies and more backups and access to diverse sources of materials.
“As an industry, there is a lot of work being done right now in diversifying with all the raw materials and also calculating or managing the supply chain a bit differently within inventory levels for raw materials… traditionally [the pharmaceutical industry] always used to select few or a just a handful of suppliers.”
Chornet highlighted one of the biggest challenges in pharma currently: “everybody is looking for alternatives for supply chain. They are looking to diversify components usage; for example, how can we reduce components usage and retrofit our processes, so we are less dependent on external components.”
The COVID-19 pandemic “forced us to be leaner, to be more efficient from a manufacturing process, from a scientific review process, from an approval process, from the logistics, all the aspects end to end in the supply chain and [there] are areas that we are continuing now to expand on and to ensure that we keep in our supply chains, in our manufacturing,” he added.
Industry collaboration
Regarding collaboration within pharma, Chornet said: “I think there is opportunity and lessons learned around how we can leverage certain capacities between different companies and within the industry warehouse; for example, logistics.
now it is a good time… [to participate] and… to compare notes not just as an industry but with the government and with the agencies [and] also focus on continuous improvement”
“During the pandemic by necessity I think there has been quite a bit of inter-industry [collaboration], but also external industry help and collaboration and that has led to a rapid supply for the world and this was groundbreaking in many aspects and a good lesson to carry on and to continue.”
Regarding the best approach to collaboration within vaccine manufacturing, Chornet remarked that “now is a good time… [to participate] and to debrief and see what we can do as an industry.” It is important, he stated, “to compare notes” not just as an industry “but with the government and with the agencies [and] also focus on continuous improvement.”
Resilience in vaccine manufacturing
The interview also covered how innovative technologies could support vaccine manufacturing resilience. Chornet again mentioned the benefits of mRNA and how that throughout the biotech industry, there are new technologies that are “either helping mRNA or are completely different and also bringing different positive or new aspects to vaccine making.”
“AI, for example, is an area that is rapidly touching or impacting all industries in the world and definitely in biotech we can leverage a lot of the digital developments… to continue improving and optimising manufacturing.”
EPR also wanted to find out what Chornet considered was most important for supporting this resilience.
“If you do not have the good quality systems and mindset and controls in place… you cannot manufacture vaccines… all the improvements that we are seeing in analytics and development of methods and the quality control, I think are really accelerating our chemical control and our understanding of vaccines and the overall quality control.
“There is a tremendous amount of opportunities with the new digital systems and platforms that we are putting in place to continue strengthening our overall quality oversight of our processes and our vaccines,” he explained.
Staff training
Reflecting upon how staff training can help deliver resilience within the manufacturing sector, Chornet noted that during the COVID-19 pandemic, “one of the challenges in the rapid ramp up that we had to do… [were the] technical challenges of installing and building the sites really, or the manufacturing lines; but then it was a recruitment formation really and support of the production folks on all the manufacturing.”
Therefore, to ensure resilience in the vaccine manufacturing space, Chornet astutely expressed that there needs to be “the right mindset, the right curiosity and the right level of execution.”
About the interviewee
Nicolas Chornet is Senior Vice President of Resilience Operations at Moderna. He has over 20 years of experience in manufacturing and operations within the pharmaceutical industry. In his current role, Nicolas leads resilience operations as part of Moderna’s manufacturing and quality network.
In his previous roles at Moderna, Nicolas was the Senior Vice President of International Manufacturing and the Site Head for Moderna’s Norwood clinical development manufacturing plant.
He joined Moderna in early 2019 following 11 years with Novartis. Nicolas obtained a degree in Chemical Engineering at the Colorado School of Mines.
This website uses cookies to enable, optimise and analyse site operations, as well as to provide personalised content and allow you to connect to social media. By clicking "I agree" you consent to the use of cookies for non-essential functions and the related processing of personal data. You can adjust your cookie and associated data processing preferences at any time via our "Cookie Settings". Please view our Cookie Policy to learn more about the use of cookies on our website.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorised as ”Necessary” are stored on your browser as they are as essential for the working of basic functionalities of the website. For our other types of cookies “Advertising & Targeting”, “Analytics” and “Performance”, these help us analyse and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these different types of cookies. But opting out of some of these cookies may have an effect on your browsing experience. You can adjust the available sliders to ‘Enabled’ or ‘Disabled’, then click ‘Save and Accept’. View our Cookie Policy page.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Cookie
Description
cookielawinfo-checkbox-advertising-targeting
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertising & Targeting".
cookielawinfo-checkbox-analytics
This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".
cookielawinfo-checkbox-necessary
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance
This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Performance".
PHPSESSID
This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
zmember_logged
This session cookie is served by our membership/subscription system and controls whether you are able to see content which is only available to logged in users.
Performance cookies are includes cookies that deliver enhanced functionalities of the website, such as caching. These cookies do not store any personal information.
Cookie
Description
cf_ob_info
This cookie is set by Cloudflare content delivery network and, in conjunction with the cookie 'cf_use_ob', is used to determine whether it should continue serving “Always Online” until the cookie expires.
cf_use_ob
This cookie is set by Cloudflare content delivery network and is used to determine whether it should continue serving “Always Online” until the cookie expires.
free_subscription_only
This session cookie is served by our membership/subscription system and controls which types of content you are able to access.
ls_smartpush
This cookie is set by Litespeed Server and allows the server to store settings to help improve performance of the site.
one_signal_sdk_db
This cookie is set by OneSignal push notifications and is used for storing user preferences in connection with their notification permission status.
YSC
This cookie is set by Youtube and is used to track the views of embedded videos.
Analytics cookies collect information about your use of the content, and in combination with previously collected information, are used to measure, understand, and report on your usage of this website.
Cookie
Description
bcookie
This cookie is set by LinkedIn. The purpose of the cookie is to enable LinkedIn functionalities on the page.
GPS
This cookie is set by YouTube and registers a unique ID for tracking users based on their geographical location
lang
This cookie is set by LinkedIn and is used to store the language preferences of a user to serve up content in that stored language the next time user visit the website.
lidc
This cookie is set by LinkedIn and used for routing.
lissc
This cookie is set by LinkedIn share Buttons and ad tags.
vuid
We embed videos from our official Vimeo channel. When you press play, Vimeo will drop third party cookies to enable the video to play and to see how long a viewer has watched the video. This cookie does not track individuals.
wow.anonymousId
This cookie is set by Spotler and tracks an anonymous visitor ID.
wow.schedule
This cookie is set by Spotler and enables it to track the Load Balance Session Queue.
wow.session
This cookie is set by Spotler to track the Internet Information Services (IIS) session state.
wow.utmvalues
This cookie is set by Spotler and stores the UTM values for the session. UTM values are specific text strings that are appended to URLs that allow Communigator to track the URLs and the UTM values when they get clicked on.
_ga
This cookie is set by Google Analytics and is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. It stores information anonymously and assign a randomly generated number to identify unique visitors.
_gat
This cookies is set by Google Universal Analytics to throttle the request rate to limit the collection of data on high traffic sites.
_gid
This cookie is set by Google Analytics and is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visited in an anonymous form.
Advertising and targeting cookies help us provide our visitors with relevant ads and marketing campaigns.
Cookie
Description
advanced_ads_browser_width
This cookie is set by Advanced Ads and measures the browser width.
advanced_ads_page_impressions
This cookie is set by Advanced Ads and measures the number of previous page impressions.
advanced_ads_pro_server_info
This cookie is set by Advanced Ads and sets geo-location, user role and user capabilities. It is used by cache busting in Advanced Ads Pro when the appropriate visitor conditions are used.
advanced_ads_pro_visitor_referrer
This cookie is set by Advanced Ads and sets the referrer URL.
bscookie
This cookie is a browser ID cookie set by LinkedIn share Buttons and ad tags.
IDE
This cookie is set by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
li_sugr
This cookie is set by LinkedIn and is used for tracking.
UserMatchHistory
This cookie is set by Linkedin and is used to track visitors on multiple websites, in order to present relevant advertisement based on the visitor's preferences.
VISITOR_INFO1_LIVE
This cookie is set by YouTube. Used to track the information of the embedded YouTube videos on a website.